Market Tracker

10/19 10:47am ET

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.63
Delayed Data
As of 10:32am ET
 -0.0101 / -0.62%
Today’s Change
1.20
Today|||52-Week Range
23.08
-68.61%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close1.64
Today’s open1.64
Day’s range1.57 - 1.65
Volume27,458
Average volume (3 months)363,837
Market cap$17.9M
Dividend yield--
Data as of 10:32am ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-62.63%
Earnings growth (this year)--
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-95.45%
P/E ratioNM
Price/Sales184.93
Price/Book2.44

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc-0.07-4.75%
NVGNNovogen Ltd0.000.00%
OGENOragenics Inc-0.01-3.77%
CBIOCatalyst Biosciences...+0.07+1.30%
Data as of 10:32am ET, 10/19/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)-$0.91
Annual revenue (last year)$145.0K
Annual profit (last year)-$55.5M
Net profit margin-38,291.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts